查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1755852

2032 年大豆嬰兒配方奶粉市場預測：按產品類型、配方、年齡層、通路、最終用戶和地區進行的全球分析

Soy-Based Infant Formula Market Forecasts to 2032 - Global Analysis By Product Type, Form, Age Group, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球大豆嬰兒配方奶粉市場預計在 2025 年達到 2.9118 億美元，到 2032 年將達到 6.397 億美元，預測期內的複合年成長率為 11.9%。

大豆嬰兒配方奶粉是奶粉植物來源牛奶替代品，專為乳糖不耐症、牛奶蛋白過敏或偏好素食或純素飲食的嬰兒設計。該產品由分離大豆蛋白製成，並添加了必需營養素，有助於正常的生長發育。雖然營養充足，但通常建議在醫生指導下使用，尤其適合有特殊飲食需求或健康狀況的嬰兒。

人們對純素和素食者的興趣日益濃厚

隨著越來越多的父母選擇植物來源飲食，大豆基嬰兒配方奶粉的需求也隨之成長。人們日益意識到純素和素食的健康益處，這推動了市場的成長。此外，對乳製品過敏和乳糖不耐症的擔憂也促使人們更加青睞大豆基替代品。監管部門對植物來源營養的支持也進一步推動了植物性營養的普及。製造商正推出創新的大豆基配方，以滿足消費者的需求。因此，對無乳嬰兒營養品的需求正穩定成長。

來自替代牛奶的競爭

儘管豆奶的偏好日益成長，但來自其他植物性和有機替代品的競爭仍然是一個挑戰。杏仁、燕麥和米配方奶粉已成為替代品，導致消費者逐漸遠離豆製品。此外，水解蛋白奶粉適用於過敏體質的嬰兒，限制了豆奶配方奶粉的攝取。對豆奶配方奶粉中植物雌激素的擔憂促使一些家長尋求替代品。監管部門對豆奶配方奶粉的審查也進一步增加了市場擴張的複雜性。

全球都市化和可支配收入

都市化的加速促使越來越多的雙薪父母尋求便利營養的嬰兒配方奶粉。可支配收入的增加使他們能夠購買營養價值高的優質豆奶粉。人們對永續和道德採購的意識日益增強，正在影響消費者的購買決策。城市中心分銷網路的不斷擴張提高了產品的可及性。電商平台在提升全球可得性發揮關鍵作用。隨著消費者偏好的演變，製造商有機會透過有針對性的創新來擴大市場覆蓋範圍。

生產成本高

由於嚴格的品質和安全標準，大豆基嬰兒配方奶粉的生產成本高昂。採購非基因改造大豆作為嬰兒營養品會增加原料成本。複雜的加工和配方要求進一步增加了生產成本。合規性和認證需要生產商進行大量投資。消費者的價格敏感度可能會限制市場的成長潛力。

COVID-19的影響

疫情擾亂了供應鏈，導致全球大豆基嬰兒配方奶粉供應面臨挑戰。疫情封鎖期間的恐慌性搶購和囤貨行為導致了暫時的短缺。人們對健康和營養的日益關注推動了對植物來源替代品的需求。隨著家長紛紛尋求線上購買配方奶粉的途徑，電商銷售額激增。製造商紛紛提高產能並最佳化通路，以應對疫情帶來的挑戰。疫情後，對韌性供應鏈策略的投資可能會持續下去。

預計奶粉市場在預測期內將佔據最大佔有率

嬰兒配方奶粉因其便利性和較長的保存期限，預計將在預測期內佔據最大的市場佔有率。由於價格實惠且易於儲存，父母更青睞嬰兒配方奶粉。配方技術的進步改善了大豆基嬰兒配方奶粉的口感和消化率。該細分市場受益於包括超級市場和藥局在內的強大分銷網路。有機和強化產品等日益增加的產品創新，正在推動其進一步普及。

預計在預測期內，醫院部門的複合年成長率最高。

由於新生兒乳糖不耐症的增多，預計醫院奶粉市場將在預測期內達到最高成長。小兒科建議對牛奶蛋白過敏的嬰兒使用大豆替代品。醫院透過早期營養計畫在推廣嬰兒配方奶粉的採用方面發揮關鍵作用。醫療保健投資的增加有助於提供醫學推薦的嬰兒配方奶粉解決方案。醫療保健提供者與嬰兒配方奶粉製造商之間的夥伴關係正在提升市場滲透率。

佔比最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於人們對植物性營養的認知不斷提高。快速的都市化和不斷成長的可支配收入推動了植物營養的普及率。嬰兒人口的成長以及人們對乳糖不耐症的擔憂推動了嬰兒配方奶粉的需求。該地區強大的零售網路促進了產品的廣泛分銷。政府推廣嬰兒營養的措施也進一步推動了市場的成長。

複合年成長率最高的地區：

由於北美擁有先進的醫療基礎設施，預計在預測期內的複合年成長率最高。主要嬰兒配方奶粉製造商的存在正在推動技術創新和產品開發。消費者對非乳製品替代品的偏好日益成長，推動了市場擴張。對嬰兒配方奶粉的監管支持正在推動大豆基嬰兒配方奶粉的普及。人們對無過敏原產品的日益關注正在影響購買決策。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球大豆嬰兒配方奶粉市場（依產品類型）

  • 低脂大豆嬰兒配方奶粉
  • 全脂大豆嬰兒配方奶粉
  • 有機大豆嬰兒配方奶粉
  • 非基因改造大豆嬰兒配方奶粉
  • 治療配方
  • 其他產品類型

6. 全球大豆嬰兒配方奶粉市場（依配方）

  • 配方奶粉
  • RTF（即食）嬰兒配方奶粉
  • 液體濃縮物

7. 全球大豆配方嬰兒配方奶粉市場（依年齡層）

  • 0 - 6個月
  • 6 - 12個月
  • 12-24個月

8. 全球大豆嬰兒配方奶粉市場（依通路）

  • 超級市場和大賣場
  • 醫院和診所
  • 藥局/藥局
  • 專賣店
  • 網路零售

9. 全球大豆嬰兒配方奶粉市場（依最終用戶）

  • 家
  • 幼稚園
  • 醫院
  • 其他最終用戶

10. 全球大豆嬰兒配方奶粉市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Abbott Laboratories
  • Danone SA
  • Nestle SA
  • Reckitt Benckiser Group plc
  • Perrigo Company plc
  • The Kraft Heinz Company
  • FrieslandCampina
  • HiPP GmbH & Co. Vertrieb KG
  • The Hain Celestial Group, Inc.
  • Else Nutrition Holdings Inc.
  • Nature's One
  • Arla Foods
  • Beingmate Baby & Child Food Co., Ltd.
  • China Feihe Limited
  • Nutribray
Product Code: SMRC29746

According to Stratistics MRC, the Global Soy-Based Infant Formula Market is accounted for $291.18 million in 2025 and is expected to reach $639.70 million by 2032 growing at a CAGR of 11.9% during the forecast period. Soy-based infant formula is a plant-based alternative to cow's milk formula, designed for infants who are lactose intolerant, allergic to cow's milk protein, or whose families prefer a vegetarian or vegan diet. Made from soy protein isolate and fortified with essential nutrients, it supports normal growth and development. While nutritionally adequate, it is typically recommended under medical guidance, especially for infants with specific dietary needs or health conditions.

Market Dynamics:

Driver:

Rising vegan & vegetarian preferences

As more parents opt for plant-based diets, the demand for soy-based infant formula is increasing. The growing awareness of health benefits associated with vegan and vegetarian diets is driving market expansion. Additionally, concerns over dairy allergies and lactose intolerance have led to a preference for soy-based alternatives. Regulatory support for plant-based nutrition is further boosting adoption. Manufacturers are responding with innovative soy-based formulations to meet consumer needs. As a result, the market is witnessing steady growth in demand for non-dairy infant nutrition solutions.

Restraint:

Competition from alternative formulas

Despite the rising preference for soy-based formulas, competition from other plant-based and organic alternatives poses a challenge. Almond, oat, and rice-based formulas are emerging as substitutes, drawing consumers away from soy options. Additionally, hydrolyzed protein formulas cater to infants with sensitivities, limiting soy-based formula adoption. Concerns over phytoestrogen content in soy formula have prompted some parents to seek alternatives. Regulatory scrutiny on soy-based formulas adds further complexity to market expansion.

Opportunity:

Global urbanization & disposable income

Rising urbanization is fueling an increase in working parents who seek convenient and nutritious infant formula solutions. Higher disposable income enables parents to afford premium soy-based formulas with enhanced nutritional profiles. Growing awareness of sustainable and ethical sourcing is influencing purchasing decisions. Expanding distribution networks in urban centers allow for greater product availability. E-commerce platforms are playing a significant role in boosting global accessibility. As consumer preferences evolve, manufacturers have an opportunity to expand market reach through targeted innovations.

Threat:

High production costs

The production of soy-based infant formula entails high costs due to strict quality and safety standards. Sourcing non-GMO soybeans for infant nutrition adds to raw material expenses. Complex processing and formulation requirements further increase manufacturing costs. Regulatory compliance and certifications demand significant investment from producers. Price sensitivity among consumers may limit market growth potential.

Covid-19 Impact

The pandemic disrupted supply chains, affecting the availability of soy-based infant formula globally. Panic-buying and stockpiling during lockdowns led to temporary shortages. Increased focus on health and nutrition heightened demand for plant-based alternatives. E-commerce sales surged as parents sought online purchasing options for formula supplies. Manufacturers adapted by enhancing production capabilities and optimizing distribution channels. The post-pandemic period is likely to see continued investment in resilient supply chain strategies.

The powdered formula segment is expected to be the largest during the forecast period

The powdered formula segment is expected to account for the largest market share during the forecast period, due to its convenience and longer shelf life. Parents prefer powdered formulas for their affordability and ease of storage. Advances in formulation technology have improved the taste and digestibility of soy-based powdered formulas. The segment benefits from strong distribution networks across supermarkets and pharmacies. Increasing product innovations with organic and fortified variants are driving further adoption.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to increasing cases of lactose intolerance among newborns. Pediatricians recommend soy-based alternatives for infants allergic to cow's milk protein. Hospitals play a crucial role in promoting specialized infant formulas through early nutrition programs. Rising healthcare investments support the availability of medically recommended formula solutions. Partnerships between healthcare providers and formula manufacturers are strengthening market penetration.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to growing awareness of plant-based nutrition. Rapid urbanization and increasing disposable income contribute to higher adoption rates. Expanding infant population and concerns over lactose intolerance drive demand for soy-based formulas. The region's strong retail network facilitates widespread product distribution. Government initiatives promoting infant nutrition further support market growth.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its advanced healthcare infrastructure. The presence of leading formula manufacturers boosts innovation and product development. Rising consumer preference for non-dairy alternatives is fuelling market expansion. Regulatory support for infant nutrition encourages growth in soy-based formula adoption. Increasing awareness of allergen-free options is influencing purchasing decisions.

Key players in the market

Some of the key players profiled in the Soy-Based Infant Formula Market include Abbott Laboratories, Danone S.A., Nestle S.A., Reckitt Benckiser Group plc, Perrigo Company plc, The Kraft Heinz Company, FrieslandCampina, HiPP GmbH & Co. Vertrieb KG, The Hain Celestial Group, Inc., Else Nutrition Holdings Inc., Nature's One, Arla Foods, Beingmate Baby & Child Food Co., Ltd., China Feihe Limited, and Nutribray.

Key Developments:

In May 2025, Else Nutrition Holdings Inc. is excited to announce its expanded footprint in the U.S. retail market with the launch of its Ready-to-Drink (RTD) products in a leading grocery retail chain. Starting May 2025, Else's clean-label Kids RTD products are available in 1,000 stores nationwide.

In April 2024, Perrigo Company plc announced that Opill(R) the first-ever daily birth control pill available without a prescription in the U.S. and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.

Product Types Covered:

  • Low-Fat Soy-Based Infant Formula
  • Whole-Fat Soy-Based Infant Formula
  • Organic Soy-Based Infant Formula
  • Non-GMO Soy-Based Infant Formula
  • Therapeutic Formulas
  • Other Product Types

Forms Covered:

  • Powdered Formula
  • Ready-to-Feed Formula
  • Liquid Concentrate

Age Groups Covered:

  • Retail 0-6 Months
  • 6-12 Months
  • 12-24 Months

Distribution Channels Covered:

  • Supermarkets and Hypermarkets
  • Hospitals & Clinics
  • Pharmacies/Drug Stores
  • Specialty Stores
  • Online Retail

End Users Covered:

  • Households
  • Day-care Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Soy-Based Infant Formula Market, By Product Type

  • 5.1 Introduction
  • 5.2 Low-Fat Soy-Based Infant Formula
  • 5.3 Whole-Fat Soy-Based Infant Formula
  • 5.4 Organic Soy-Based Infant Formula
  • 5.5 Non-GMO Soy-Based Infant Formula
  • 5.6 Therapeutic Formulas
  • 5.7 Other Product Types

6 Global Soy-Based Infant Formula Market, By Form

  • 6.1 Introduction
  • 6.2 Powdered Formula
  • 6.3 Ready-to-Feed Formula
  • 6.4 Liquid Concentrate

7 Global Soy-Based Infant Formula Market, By Age Group

  • 7.1 Introduction
  • 7.2 0-6 Months
  • 7.3 6-12 Months
  • 7.4 12-24 Months

8 Global Soy-Based Infant Formula Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets and Hypermarkets
  • 8.3 Hospitals & Clinics
  • 8.4 Pharmacies/Drug Stores
  • 8.5 Specialty Stores
  • 8.6 Online Retail

9 Global Soy-Based Infant Formula Market, By End User

  • 9.1 Introduction
  • 9.2 Households
  • 9.3 Daycare Centers
  • 9.4 Hospitals
  • 9.5 Other End Users

10 Global Soy-Based Infant Formula Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Danone S.A.
  • 12.3 Nestle S.A.
  • 12.4 Reckitt Benckiser Group plc
  • 12.5 Perrigo Company plc
  • 12.6 The Kraft Heinz Company
  • 12.7 FrieslandCampina
  • 12.8 HiPP GmbH & Co. Vertrieb KG
  • 12.9 The Hain Celestial Group, Inc.
  • 12.10 Else Nutrition Holdings Inc.
  • 12.11 Nature's One
  • 12.12 Arla Foods
  • 12.13 Beingmate Baby & Child Food Co., Ltd.
  • 12.14 China Feihe Limited
  • 12.15 Nutribray

List of Tables

  • Table 1 Global Soy-Based Infant Formula Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Soy-Based Infant Formula Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Soy-Based Infant Formula Market Outlook, By Low-Fat Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 4 Global Soy-Based Infant Formula Market Outlook, By Whole-Fat Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 5 Global Soy-Based Infant Formula Market Outlook, By Organic Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 6 Global Soy-Based Infant Formula Market Outlook, By Non-GMO Soy-Based Infant Formula (2024-2032) ($MN)
  • Table 7 Global Soy-Based Infant Formula Market Outlook, By Therapeutic Formulas (2024-2032) ($MN)
  • Table 8 Global Soy-Based Infant Formula Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Soy-Based Infant Formula Market Outlook, By Form (2024-2032) ($MN)
  • Table 10 Global Soy-Based Infant Formula Market Outlook, By Powdered Formula (2024-2032) ($MN)
  • Table 11 Global Soy-Based Infant Formula Market Outlook, By Ready-to-Feed Formula (2024-2032) ($MN)
  • Table 12 Global Soy-Based Infant Formula Market Outlook, By Liquid Concentrate (2024-2032) ($MN)
  • Table 13 Global Soy-Based Infant Formula Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 14 Global Soy-Based Infant Formula Market Outlook, By 0-6 Months (2024-2032) ($MN)
  • Table 15 Global Soy-Based Infant Formula Market Outlook, By 6-12 Months (2024-2032) ($MN)
  • Table 16 Global Soy-Based Infant Formula Market Outlook, By 12-24 Months (2024-2032) ($MN)
  • Table 17 Global Soy-Based Infant Formula Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 18 Global Soy-Based Infant Formula Market Outlook, By Supermarkets and Hypermarkets (2024-2032) ($MN)
  • Table 19 Global Soy-Based Infant Formula Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 20 Global Soy-Based Infant Formula Market Outlook, By Pharmacies/Drug Stores (2024-2032) ($MN)
  • Table 21 Global Soy-Based Infant Formula Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 22 Global Soy-Based Infant Formula Market Outlook, By Online Retail (2024-2032) ($MN)
  • Table 23 Global Soy-Based Infant Formula Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Soy-Based Infant Formula Market Outlook, By Households (2024-2032) ($MN)
  • Table 25 Global Soy-Based Infant Formula Market Outlook, By Daycare Centers (2024-2032) ($MN)
  • Table 26 Global Soy-Based Infant Formula Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 27 Global Soy-Based Infant Formula Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.